Global Plasma Fractionation (Albumin, Immunoglobulin,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Global Plasma Fractionation (Albumin, Immunoglobulin, Factor VIII, Protease Inhibitors) Market - Global Forecast to 2019

Dublin, Jan. 22, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/z7wd4k/plasma ) has announced the addition of the "Plasma Fractionation Market by Product, Application & by End-user - Global Forecast to 2019" report to their offering.

The global plasma fractionation market is estimated to be worth around $16,573.4 million in 2014 and grow at a CAGR of 8.9% during the forecast period of 2014 to 2019. This market is mainly driven by increasing aging population, growing number of hemophilic patients, increased diagnosis rate, and growing prophylactic treatment. Moreover, the increasing off-label use of albumin and immunoglobulin in various chronic diseases is also contributing to market growth. However, the high cost and serious adverse effects of plasma products and the emergence of recombinant products are inhibiting market growth to a certain extent.

The global plasma fractionation market is divided on the basis of product, application, and end user. Based on type of product, the market is mainly segmented into albumin, immunoglobulins, coagulation factor concentrates, and others. The immunoglobulin segment is further subsegmented into intravenous immunoglobulin (IVIg), subcutaneous immunoglobulin (SCIg), and others.

Coagulation factor concentrates are subsegmented into factor VIII, factor IX, factor XIII, prothrombin coagulation concentrates, Von Willebrand factors, and fibrinogen concentrates. Various applications such as neurology, hematology, immunology, and critical care are analyzed in the report. By end users, the market is divided into the hospitals and clinics, clinical research laboratories, and academic institutes segments.

By region, this market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW), which are further analyzed at the country-level. The research report discusses the key market drivers and restraints of, and the opportunities in, the global plasma fractionation market and its submarkets.

In 2013, the immunoglobulin segment accounted for the largest share of the market. This can be attributed to the increasing aging population with neurological and autoimmune disorders, off-label use, and prophylactic therapy of IVIg. In addition, IVIg is being used in a wide range of conditions such as adult respiratory distress syndrome, fibrosis, connective tissue disease, encephalitis, heart failure, and Alzheimer's disease. Positive results in such application areas would increase the demand for IVIg in the future.

North America represented the largest regional market in 2013, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific region represents the fastest-growing market for the plasma fractionation market, primarily due to the increasing aging population, growth in the overall healthcare industry, increasing use of immunoglobulins, improved economy, rising number of hemophilic patients, growing use of albumin in China, and increasing awareness of technologically advanced products in these regions.

Major players in the global market are Baxter International, Inc. (U.S.), Grifols SA (Spain), CSL Ltd. (Australia), Octapharma AG (Switzerland), Kedrion (Italy), Bio Product Laboratory (U.K.), Sanquin (Netherlands), Laboratoire Fran�ais du Fractionnement et des Biotechnologies (France), and Biotest (Germany).


Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Global Plasma Fractionation Market, By Product

8 Global Plasma Fractionation Market, By Application

9 Global Plasma Fractionation Market, By End User

10 Global Plasma Fractionation Market, By Geography

11 Competitive Landscape

12 Company Profiles

13 Appendix


Companies Mentioned:

  • Baxter International, Inc.
  • Biotest
  • Chinese Biological Products, Inc.
  • Csl, Ltd.
  • Grifols International SA
  • Kedrion
  • Kedrion S.P.A.
  • LFB SA
  • Octapharma AG
  • Shanghai Raas Blood Products Co., Ltd.


For more information visit http://www.researchandmarkets.com/research/z7wd4k/plasma

CONTACT:

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Biotechnology

Scroll down for more posts ▼

Top 10 Most Recent News Articles

U.S. Employers Signal a Deeper Multilingual Skills Gap

Updated Category News Views 125

A language gap rarely makes the loudest noise in an earnings call, yet it can quietly wreck a sales effort, a hiring plan, or a customer relationship. ACTFL's updated 2026 employer study puts some hard edges around that problem: U.S. businesses say multilingual capability is not a nice cultural accessory. It is increasingly part of operating the business. Demand Has Moved...

Continue Reading
Teva’s R&D Exit Puts Disclosure Questions in Focus

Updated Category News Views 114

An abrupt departure in the drug business is never just an HR memo. Teva Pharmaceutical Industries shares reportedly dropped about 8.74% after Eric Hughes, the company’s executive vice president of Global R&D and chief medical officer, left effective immediately. That kind of move rattles investors because R&D leadership is not decorative furniture at a pharmaceutical...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 110

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
KidneyVoter Push Turns Patient Frustration Into Clout

Updated Category News Views 313

A ballot registration drive rarely tells the whole story, but it can reveal where the pressure is building. The American Association of Kidney Patients says its 2026 nonpartisan KidneyVoter™ effort, “50 States in 50 Days,” reached constituencies in every state after launching September 14. That does not produce a clean vote total or prove legislators will suddenly...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 73

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
Oatly’s $4.13 Tender Offer Is a Legal Detour, Not a Sale

Updated Category News Views 122

A $4.13 cash offer trading against a $7.17 close is the sort of thing that makes investors squint hard, and Verlinvest is practically waving a flag telling them why. This is not a conventional attempt to buy Oatly Group AB. It is a technical tender offer built to satisfy Swedish takeover rules while Verlinvest buys out its joint-venture partner’s interest in Oatly’s...

Continue Reading
Atalanta Takes Formal Verification Into Critical Systems

Updated Category News Views 515

A week of bewildering infrastructure failures is a nasty time to discover nobody can explain the machinery. That was the backdrop for Atalanta CEO and co-founder Anjana Rajan at the National Academies of Sciences, Engineering, and Medicine's Cyber Resilience Forum, which concluded November 20 after two days in Washington. Her central point deserves more attention than the...

Continue Reading
E-Rate Risk and Data Center Rules Demand Attention

Updated Category News Views 71

America’s digital plumbing is getting squeezed at both ends: the public connections nobody notices until they fail, and the industrial-scale computing boom everybody suddenly wants built yesterday. Connected Nation’s two bonus podcast episodes from the Broadband Nation Expo in New Orleans put those pressures side by side, and it is a more useful pairing than it may...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 158

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
Highmark’s 2026 Rebound Has a Few Asterisks Attached

Updated Category News Views 65

The Headline Needs a Pencil, Not a Highlighter A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the...

Continue Reading

Top 5 Most Recently Viewed Articles

The Hiring Crisis for Gen Z: Understanding Key Economic Factors

Updated Category News Views 472

The Hiring Crisis for Gen Z In today's economy, young Americans, particularly those under 25, are experiencing a significant challenge in securing employment. This issue, marked by increasing unemployment rates among recent graduates, is creating alarm. Most agree that the factors influencing this crisis point to a stagnation in hiring practices rather than advancements...

Continue Reading
Recent Class Action Highlights Concerns Around Bumble Inc. Shares

Updated Category News Views 78

Understanding the Recent Class Action Against Bumble Inc. The landscape of online dating and social networking continues to evolve, with Bumble Inc. playing a significant role in shaping user experiences. Recently, a securities class action lawsuit has been filed in the United States District Court for the Western District of Texas against Bumble Inc. (BMBL). This...

Continue Reading
Analyzing Li Auto Inc's Market Sentiment and Short Interest

Updated Category News Views 165

Understanding Market Sentiment for Li Auto Inc Li Auto Inc (NYSE: LI) has recently witnessed a noteworthy shift in its short interest percentage. As reported, the company’s short interest has decreased by 13.66%, with approximately 20.65 million shares being sold short. This figure represents about 5.12% of the total shares that are available for trading. The data...

Continue Reading
Equity Markets Take a Breather During Holiday Pause

Updated Category News Views 245

Markets Hold Steady as Investors Reflect With the US markets taking a break for the Thanksgiving holiday, global equities have collectively paused for a moment of reflection. This calmness among investors is primarily influenced by current expectations regarding a dovish shift in Federal Reserve policy. Speculation is high, with many assigning about an 80% probability for...

Continue Reading
University of Phoenix's New Leadership in Counseling: What’s Next?

Updated Category News Views 358

New Leadership Spotlight: Yurandol Thompson Elevated The University of Phoenix has gone and done it again, appointing Yurandol Thompson as Associate Dean for Counseling, effective January 29, 2026. Now, this isn’t just any old shake-up. Dr. Thompson brings over a decade of experience in clinical operations and programmatic excellence. I mean, come on—sounds impressive...

Continue Reading